Figure 1.
Basal net t-PA antigen release (A) and activity release (B) during placebo and 17β-estradiol (1 mg/d) treatment, in the presence and absence of intraarterial enalaprilat. *P=0.039 vs vehicle, †P=0.033 vs placebo, in posthoc analysis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.